Literature DB >> 1335376

A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis.

A Belleli1, S Shany, J Levy, R Guberman, S A Lamprecht.   

Abstract

The intriguing observation has been made that 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] receptors are present in tissues not involved in calcium homeostasis and that 1,25(OH)2D3 exerts an antiproliferative, differentiation-promoting action in a variety of cancer cell lines, including cells of the large intestine. It was therefore deemed of interest to study 1,25(OH)2D3 expression and biological activity in a murine model of colon carcinogenesis. Colon carcinogenesis was induced in male rats by the sequential administration of 1,2-dimethylhydrazine dihydrochloride (DMH). Levels and binding characteristics of 1,25(OH)2D3 receptors were assessed in control and DMH-treated rat colonic mucosal high-speed supernatants. In concurrent studies, 1,25(OH)2D3 was administered (s.c., 400 ng/rat) prior to, together with and after DMH challenge and the activity of ornithine decarboxylase (ODC), a growth-related DMH-induced enzyme, was determined in colonic cytosols. Serum Ca2+ levels were measured concurrently. Rats submitted to identical treatment schedules were killed 10 weeks after termination of DMH administration and the whole colon was opened and examined for tumors. The results show that (i) rat colonic mucosa possesses a single class of high-affinity 1,25(OH)2D3 receptors; (ii) DMH administration provokes a marked reduction (50%) in 1,25(OH)2D3 binding sites without affecting Kd values; (iii) DMH administered concurrently with 1,25(OH)2D3 suppressed the vitamin D-induced hypercalcemia and restored serum Ca2+ concentrations to basal levels; and (iv) 1,25(OH)2D3 delivered prior to DMH challenge obliterated the typical DMH-induced early colonic ODC activity peak and markedly reduced (50%) the number of colon adenocarcinomas. The present findings indicate that a colon-specific potent carcinogen interferes with the biological expression of 1,25(OH)2D3 and that vitamin D administered prior to a carcinogenic insult is able to reduce significantly the incidence of colon tumors, presumably acting as an antiproliferative or differentiation-promoting agent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335376     DOI: 10.1093/carcin/13.12.2293

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.

Authors:  Charles Giardina; Masako Nakanishi; Awaad Khan; Anton Kuratnik; Wanli Xu; Bruce Brenner; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-14

3.  Upregulation of 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase by butyrate in Caco-2 cells.

Authors:  Oliver Schröder; Sinan Turak; Carolin Daniel; Tanja Gaschott; Jürgen Stein
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

4.  Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancer.

Authors:  Amy A Irving; Lori A Plum; William J Blaser; Madeline R Ford; Chao Weng; Linda Clipson; Hector F DeLuca; William F Dove
Journal:  J Nutr       Date:  2014-12-24       Impact factor: 4.798

Review 5.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

6.  1,25 dihydroxyvitamin D3 stimulates phospholipase C-gamma in rat colonocytes: role of c-Src in PLC-gamma activation.

Authors:  S Khare; M J Bolt; R K Wali; S F Skarosi; H K Roy; S Niedziela; B Scaglione-Sewell; B Aquino; C Abraham; M D Sitrin; T A Brasitus; M Bissonnette
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 7.  Mechanism of action of vitamin D and the vitamin D receptor in colorectal cancer prevention and treatment.

Authors:  Stephen W Byers; Tracey Rowlands; Marcy Beildeck; Yong-Sik Bong
Journal:  Rev Endocr Metab Disord       Date:  2012-03       Impact factor: 6.514

Review 8.  Vitamin D resistance and colon cancer prevention.

Authors:  Charles Giardina; James P Madigan; Cassandra A Godman Tierney; Bruce M Brenner; Daniel W Rosenberg
Journal:  Carcinogenesis       Date:  2011-12-16       Impact factor: 4.944

Review 9.  Chemoprevention of colorectal cancer.

Authors:  M Langman; P Boyle
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

10.  Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.

Authors:  Min Cui; Yan Zhao; Kenneth W Hance; Andrew Shao; Richard J Wood; James C Fleet
Journal:  J Cell Physiol       Date:  2009-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.